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Sllmmal'y 
The Jarisch-Herxheimer Reaction (J-HR) is a clinical syndrome occurring soon after the first 
adequate dose of an antimicrobial drug to treat infectious diseases such as Lyme disease, syphilis, 
and relapsing fever. Previous attempts to identify factors mediating this reaction, that may cause 
death, have been unsuccessful. We conducted a prospective trial in ,AAdis Ababa, Ethiopia on 
17 patients treated with penicillin for proven louse-borne relapsing fever due to Borrelia recurrentis 
to evaluate the association of symptoms with plasma levels of tumor necrosis factor (TNF), 
interleukins 6, and 8 (1I,-6 and -8). 14 of the 17 (82%) patients experienced a typical  J-HR consisting 
of rigors, a rise in body temperature (1.06  +  0.2~  peaking at 2 h, leukopenia (7.4  _+  0.6 
x  10 -3 cells/mm  3) at 4  h,  a  slight  decrease,  and then rise of mean arterial blood pressure. 
Spirochetes were cleared from blood in 5  _+  1 h  after peniciUin.  There were no fatalities,  but 
constitutional symptoms were severe during J-HR.  Plasma TNF,  Ib6,  and -8 were raised in 
several patients on admission, but a seven-, six-, and fourfold elevation of these plasma cytokine 
concentrations over admission levels was  detected, respectively, occurring in  transient  form 
coincidental with observed pathophysiological changes of  J-HR. Elevated plasma cytokine levels 
were not detected in the three patients who did not suffer J-HR.  We conclude that the severe 
pathophysiological changes characterizing the J-HR occurring on penicillin treatment of louse- 
borne relapsing fever are closely associated with transient elevation of plasma TNF,  ID6, and 
-8 concentrations. 
T 
he Jarisch-Herxheimer Reaction (J-HR) t is an epony- 
mous title for a clinical phenomenon, first described at 
the turn of the century, resulting from the treatment of early 
syphilis with mercury (1, 2).  The original description was 
that the spots of roseola syphilis became more defined and 
numerous on treatment, and that the reaction was accompa- 
nied by fever, sweating, and anorexia which occurred with 
24 h of mercury inunction. It is now recognized that similar 
transient reactions occur soon after the first adequate dose 
of a drug, usually an antibiotic, in the treatment of a wide 
spectrum of infectious diseases (3). Antibiotic treatment of 
spirochetal infections, for example syphilis,  relapsing fever, 
yaws, leptospirosis, Lyme disease, and Vincent's angina, has 
typically been identified with J-HR,  but the phenomenon 
has been described in many other bacterial infections. In ad- 
1 Abbreviations used in this paper: J-HR., Jarisch-Herxheimer Reaction. 
dition, J-HR has been described in protozoal infection. For 
example, in African trypanosomiasis, it is a serious compli- 
cation of treatment (4). 
Pathophysiological changes occurring on penicillin treat- 
ment of early syphilis have been previously documented (5), 
and consist of an increase in body temperature of more than 
0.8~  peaking between 6 and 8 h, often with rigors, associated 
with a fall in systemic arterial blood pressure and an increase 
in metabolic rate. The clinical worsening of symptoms as- 
sociated with antibiotic treatment of louse-borne relapsing 
fever, caused by Borrelia  recurrentis, is the most severe form 
of J-HR documented. Patients with this infection present 
with high fever, severe constitutional disturbance, hepatalgia, 
and splenomegaly (3). The diagnosis of relapsing fever is made 
by microscopic observation of spirochetes, typical of Borrelia 
recurrentis, on Wright's stained blood smears. The level ofbac- 
teremia may be intense with densities of up to 10  s organisms 
per mm -3.  The name relapsing fever describes one of the 
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spontaneous resolution of high pyrexia, usually by crisis, within 
10 d, followed by transient remission lasting 5 or 6 d, fol- 
lowed by relapse of symptoms. Each remission is accompa- 
riled by the production of IgG and IgM specific for the respon- 
sible bacterial strains causing relapse, and up to four relapses 
may occur during  the course of the infection. 
The J-HR of relapsing fever may be fatal with a mortality 
approaching 40%  (6).  The J-HR  of louse-borne relapsing 
fever (7-9) is very predictable in its form, and is similar to 
that of syphilis, but it occurs sooner after the administration 
of antibiotics, at "~90 rain, and is associated with consider- 
ably more severe constitutional disturbances. It is hardly sur- 
prising that the severe pathophysiological changes of the J-HR 
of relapsing fever have provided a paradigm  for studies  on 
the pathogenesis of inflammation and shock. However, pre- 
vious studies aimed at defining the nature of mediators in- 
volved in  the etiology of this  syndrome have failed.  Since 
many of the features of J-HR resemble those now known 
to be caused by cytokines in man or animals, we have carried 
out experiments to test the hypothesis that the J-HR of louse- 
born  relapsing  fever is  associated  with  the  appearance  of 
cytokines, TNF,  IL-6, and  -8 in the circulation. 
Materials and Methods 
Selection of Patients.  Patients attending the emergency outpa- 
tient clinic of the Black Lion Hospital, Addis Ababa, with a proven 
diagnosis of relapsing fever, were included in the study. The diag- 
nosis of relapsing fever was made on clinical suspicion,  and proven 
by visual identification of Borrelia recurrentis organisms on blood 
smears stained with Wright's stain which were examined using 
light microscopy. Patients were excluded from the study ff evidence 
of any other infection was found and in particular, if malarial para- 
sites were seen on the blood smear in addition to Borrelia. Only 
patients experiencing the first episode of f~.ver  in the course of  R recur- 
rentis infection were inchded. In all, 17 patients were enrolled into 
the study.  The age range was 14-40 yr old, and all patients were 
male. 
Protocol and Clinical Parameters.  Patients were nursed throughout 
the study reclining on a bed. Clinical measurements of rectal tem- 
perature (using a mercury thermometer) and blood pressure were 
made on admission until steady values had been obtained, then im- 
mediately before intr#muscular injection of 600,000 U procaine pen- 
icillin, and at 0.5, 1, 2, 4, 8, 12, and 24 h after injection. In addi- 
tion, 10 ml of blood were drawn from a peripheral vein at the same 
time points, and placed into endotoxin-free tubes containing EDTA 
as anticoagulant. Thin blood smears were made on glass micro- 
scope slides and stained using Wright's stain.  In addition, an ali- 
quot of blood was taken for dilution and estimation of total white 
cell count using a hemocytometer. The mean of three estimations 
of white cell count was taken for each blood sample. Each blood 
sample was centrifuged at 1,000 g for 5 min, and plasma was im- 
mediately frozen in aliquots and stored at  -20~  before cytokine 
assay. Microscopy of the stained blood films was carried out by 
an independent observer who examined them by eye for the pres- 
ence of R  recurrentis. A minimum of 25 microscopic fields (x 100) 
were examined for the presence of the organism. A negative score 
was not given until all microscopic fields examined were free of 
the organism. Patients were discharged from the hospital at 24 h, 
but some discharged themselves  after 12-24 h. 
Cytokine  Assays.  All cytokine assays were performed in the 
Department of Pathology, the University of Michigan. Samples 
were assayed within 3 mo of aspiration, and were continuously 
maintained in  -20~  until the time of assay. Measurements were 
made in a blinded fashion so that those investigators handling coded 
samples were unaware of patients' clinical details or of the timing 
of samples. 
TNFAnalysis.  TNF bioactivity was assayed using the highly 
sensitive cell line, WEHI 164, subclone 13 (the generous gift of 
Anders Waage, University of Trondheim, Norway), which is able 
to detect TNF at a concentration of 2 pg/ml (10). We have previ- 
ously shown that this assay is unaffected by II.-1, -2, or -6, and 
that there is no synergy between interferon-'), and TNF in this 
assay (11). Briefly, samples were serially diluted in 96-well micro- 
titer phtes. The WEHI cells were resuspended at 5  x  10  ~ cells/ml 
in RPMI 1640 with 10% FCS, 2 mM t-glutamine, and 0.5 #g/ml 
actinomycin D (Calbiochem Corp., La Jolla, CA). The next day, 
cell  lysis  was  detected  by  adding  MTT-tetrazolium  (3-[4,5- 
dimethylthiazol-2-yl]-2,5-diphenyltetrazolium  bromide;  thiazol 
blue) and incubating the plates an additional 4 h. The dark purple 
tetrazolium salts were then dissolved in acidified isopropanol. Units 
of TNF were calcuhted based on a recombinant human standard 
run in the same assay. 
I1_,6 Assay.  The Ib6 assay was performed using the B9 cell line, 
which is very sensitive to Ib6. Briefly, serial dilutions of the samples 
were placed into 96-weU microtiter plates,  to which were added 
5,000 B9 cells in IMDM with 2 mM t-glutamine, 25 mM Hepes, 
1% penicillin/streptomycin, and 10% FCS (12). The cells were in- 
cubated for 68 h at 37~  and pulsed for the final 6 h with MTT- 
tetrazolium. The crystals were dissolved with acidified isopropanol, 
and the units calculated based on a standard curve run in the same 
assay. We have previously established the specificity of the B9 assay 
for IL-6, and have shown that it is unaffected by multiple other 
cytokines (13). 
IL,8 ELISA.  Ib8 was measured with an ELISA procedure after 
a previously described protocol (14). A polyclonal rabbit anti-Ib8 
antibody was prepared by repeated intradermal injections of purified 
rib8. The IgG from high-titer antisera was purified on protein-A 
agarose columns (Pierce Chemical Co., Rockford, IL). ELISA plates 
(Nunc-Immuno Plate Maxisorb, Neptune, NJ) were coated with 
50 ~l/well of anti-IL-8 diluted to 1/~g/ml in borate-buffered saline 
(50 mM H3BO3, 120 mM NaC1, pH 8.6) and incubated overnight 
at 4~  The plates  were washed 3 times with wash buffer (PBS 
with 0.05% vol/vol Tween 20), and blocked for 1-2 h with PBS 
containing 2% BSA at 37~  50 #l of sample was placed in each 
well, incubated for I h at 37~  and the plates were then washed. 
Next, biotinylated anti-Ib8 was added (3.5/~g/ml,  50 t~l/well, 
prepared in wash buffer with 2% FCS), the plates  incubated at 
37~  for 30 min, and then washed. Avidin-horseradish  peroxidase 
(Dako Corp., Carpinteria, CA) was diluted 1:5,000,  100 ~l was 
added to each well, and the plates  were incubated for 30 rain at 
37~  After washing, 100 ~1 of substrate solution was added (0.67 
mg/ml orthopenylenediamine dichloride [Dako Corp.], 0.0125% 
H202 in 25 mM citrate phosphate buffer, pH 5.0), the color was 
developed for 4-5 rain, and then stopped by adding 50 ~1 of 3 M 
HzSO4. All samples were run in duplicate,  and the concentration 
of Ib8 was calculated from a standard curve prepared with rlL-8. 
StatisticalAnalTsis.  The changes in each cytokine level were ana- 
lyzed by repeated measures  of analysis of variance,  to determine 
if there was a difference between the time points. All cytokines 
demonstrated a difference.  Since the data was not normally dis- 
tributed, the values at the various time points were compared with 
the admission  levels by the Wilcoxon rank sum test. 
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Results 
Patients 
17 patients were enrolled in the study. Patients were all 
febrile on admission with rectal temperature of 39.5  _+ 0.9~ 
(SEM),  and had been iU with symptoms consistent with a 
first episode ofR recurrentis  infection for 4.1  _+  1.0 d (SEM) 
before inclusion in the study. 14 patients (82%) experienced 
a severe J-HR with rigors and profound constitutional symp- 
toms. Three patients experienced no J-HR reaction.  There 
were no deaths in the study period, and all patients were dis- 
charged from the hospital.  All patients  completed  12 h  of 
study and 11 patients completed 24 h of study. Six discharged 
themselves from the hospital early, between  12 and 24 h. 
Clinical Parameters 
Fig. 1 shows results of clinical parameters measured during 
the study as a function of time. Rigors were experienced by 
all 14 patients experiencing J-HR and occurred between 60 
and 120 rain after penicillin administration,  each episode lasting 
between 20 and 30 rain.  Even though all patients were fe- 
brile on admission to the study, all 14 patients sufferingJ-HR 
experienced a rise in body temperature which peaked at 120 
min of 1.06  +  0.2~  (SEM) and coincided with rigors.  In 
addition,  a leukopenia (7.4  _+  0.6  x  10 -3 cells mm -3) be- 
ginning with the onset of rigor was documented.  Further- 
more,  the typical small decrease then rise in mean arterial 
blood pressure was observed. Spirochetemia, while not being 
quantitatively recorded, had disappeared in all patients within 
a mean of 4.5 h after antibiotic treatment was commenced. 
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Figure 1.  Kinetics of symptomatology  of J-HR. Penicillin was given 
intramuscularly at time 0. The symptoms consisted of the rapid elevation 
of temperature (shown as increase over admission temperature),  decrease 
in white blood cells, and initial slight rise in blood pressure followed by 
hypotension. These values are all displayed as the mean for 10-14 patients. 
(R~x~) Mean time of clearance of spirochetemia. (H) Range for time 
of onset of rigors. 
Table  1.  Peripheral  Blood Cytokine Levels during the 
Jarisch-Herxheimer Reaction 
Time  TNF  IL-6  IL-8 
h 
0 
Plasma Cytokine Concentrations  0.5 
Admission to Study.  Plasma TNF levels were elevated (> 3 
pg/ml) on admission to the study in nine patients. The range  1 
of plasma levels  at  this time was 3 pg/ml-t  to 55 pg/ml. 
Admission plasma Ib6 levels were elevated in 12 patients with  2 
a range of 90-6,673 pg/ml.  Similarly elevated Ib8 levels in 
plasma were detected in eight of the patients with a range  4 
of 76-846 pg/ml. 
During  J-HR.  Results of plasma cytokine concentrations  8 
during J-HR are shown in Table 1.  A  transient  release  of 
all three cytokines was measured with peak values occurring  12 
2-4 h  after penicillin  administration  (126  _  38 pg/ml  for 
TNF; 9,578  _+  1,808 pg/ml for II.-6; 8,102  -+  4,491 pg/ml 
for II.-8).  By 12 h, when the three main clinical parameters  24 
measured had returned to normal levels, the circulating con- 
centrations of all three cytokines had fallen dramatically from 
the peak levels recorded. At 24 h after antibiotic administra- 
tion, plasma cytokine concentrations had returned to admis- 
sion levels for TNF, and II.-6 and were not detectable for IL-8. 
The pattern of cytokine appearance in plasma was interesting 
pg/ml  pg/ml  pg/ml 
15  _+  5  1,478  _+ 527  173  +  65 
0--55  0-6,673  0-848 
37  -+  14  1,020  -+ 369  171  +  67 
0-142  0-5,358  0-1,001 
38  -+  13  1,375  _+ 435  168  _+ 56 
0-137  0-4,940  0-871 
86  +  23  3,836_+  651  503  _+ 330 
0-232  1,261-9,975  0-4945 
126  +  38  9,578  _+  1,808  8,102  _+ 4,991 
0-469  2,262-28,447  109-70,000 
8  _+ 4  2,003  _+ 696  216  +  111 
0-40  66-9,403  0-1,567 
12  _+ 7  289  _+  159  178  _+ 69 
0-51  0-1,841  0-639 
14  -+  10  40_+  21  ND 
0-47  0-245 
At the indicated time points after administration of penicillin, blood sam- 
ples were drawn and cytokine levels were measured in plasma. Each value 
is the mean •  SEM for 6-14 patients at each time point. Values on the 
second line represent  the range observed at each time point. 
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Figure 2.  Kinetics  of cytokine  release. Data are expressed  as fold in- 
crease over  admission  levels. Compared  with baseline  levels,  TNF showed 
the most rapid induction, and attained  the greatest  relative  increase.  TNF 
is significantly  increased  over  baseline  by I h, II~6  by 2 h, and IL-8  by 4 h. 
(Fig. 2). Since the patients had been symptomatic for an av- 
erage of 4 d before diagnosis, it was not surprising that sev- 
eral patients had circulating cytokines detectable before the 
initiation of antibiotic treatment. To provide a clearer under- 
standing of the relative changes in cytokine levels, the data 
in Fig. 2 is expressed as a fold increase over admission levels. 
These data show that TNF was the most rapidly induced, 
and showed the greatest increase relative to admission levels. 
A detailed description of the rise in plasma cytokine con- 
centrations and body temperature in the early phase of the 
J-HR is shown in Fig.  3 in conjunction with the time of 
onset of rigor. This figure shows that TNF is elevated over 
admission  levels  within  30  min.  These TNF  levels were 
significantly greater than pretreatment controls at the 1 h 
time point (Wilcoxon rank sum test), whereas I1:6 and -8 
levels were not elevated above baseline at this time point. 
Plasma II.-6 was elevated above admission at the 2 h timepoint, 
and I1:8 at the 4 h time point (all comparisons made using 
the Wilcoxon rank sum test). Thus, the evolution of plasma 
cytokine levels in this form of J-HR occurred in a distinct 
temporal sequence with the early, rapid rise in TNF being 
sequentially followed by I1:6 and then by -8. This figure clearly 
shows the relationship to the appearance of plasma cytokines 
with the development of rigors and pyrexia. TNF appeared 
before the onset of symptoms, I1:6 was detected as the symp- 
toms developed, and IL-8 was detected well after the onset 
of rigors and pyrexia. 
Discussion 
The J-HR is a well-known, but infrequently diagnosed 
complication of antimicrobial therapy. The reaction has been 
documented in the treatment of many bacterial infections (3), 
but particular attention has been focused on the phenomenon 
in spirochetal infections, namely syphilis (5), relapsing fever 
Figure 3.  Early  kinetics of cytokine  release  and development  of symp- 
toms. The change  in temperature, and development  of rigors is shown 
relative  to the elevation  of  plasma  cytokine  concentration.  The rise  of  plasma 
TNF concentrations  preceded  the elevation  in temperature  and develop- 
ment of rigors, whereas  elevation  of  plasma  IL6 coincided  with these  symp- 
toms. Elevation  of plasma ID8 concentration  lagged  behind the develop- 
ment of symptoms. All values are mean _+ SEM for 10-14 patients. 
(6-9), and leptospirosis (15). There has been considerable de- 
bate in the past concerning the nature and the identity of 
the mediators involved in the severe clinical  manifestations 
of the J-HR, particularly for syphilis and relapsing fever, but 
no definitive etiological explanation for the phenomenon has 
emerged. The present study sheds light on this question for 
the first time, and suggests that a cytokine cascade consisting, 
at the least, of TNF, I1:6 and 8, may be responsible. We have 
demonstrated that these cytokines appear in the circulation 
in transient fashion related to the appearance of severe symp- 
toms, and pathophysiological changes associated with the most 
severe form of the J-HR reaction, namely those associated 
with relapsing fever caused by/~  recurrentis  infection. 
Analysis of the plasma cytokine profiles demonstrates that 
the appearance of elevated TNF in the plasma precedes that 
of I1:6,  which in turn precedes that of II:8. In the current 
study 82% of patients suffered a J-HR, a percentage consis- 
tent with published data of previous studies in this condition 
(6, 7).  The three patients who did not experience a J-HR 
in the current study were cured of/~ recurrentis bacteremia, 
and became apyrexial after penicillin treatment, but demon- 
strated no release of any of the three measured cytokines. 
The peak plasma levels of TNF measured in this study of 
126  +  38 pg/ml (range 0-469)  are close to levels detected 
upon hospital admission of patients who subsequently died 
of menigococcal bacteria (16), and slightly lower than peak 
levels of TNF detected in plasma of human volunteers receiving 
bolus infusion of endotoxin (17). In addition, the peak de- 
tected plasma levels of I1:6,  namely 9,578  _+  1,808 pg ml- 1 
(range 2,262-28,447),  are comparable with those measured 
previously in septic shock and bacteremia (18), but consider- 
ably higher than human volunteers receiving bolus infusion 
of endotoxin (19) or rTNF (20). Elevated levels of plasma I1:8 
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but elevated levels have been detected in a primate model of 
bacteremia (21). Bolus infusion of endotoxin into human 
volunteers has been reported to cause a rise in plasma IL-8 
concentration (19), but peak levels reported in that study were 
only "~10% of the peak values detected in the study reported 
here on J-HR. 
Thus,  the  peak  values  of the  cytokine concentrations 
recorded in this J-HR study are of the same order of magni- 
tude as those recorded in previous studies of lethal bacter- 
emia. In this study of the J-HR of relapsing fever no fatali- 
ties occurred, however severe  pathophysiological changes were 
documented. The transient nature of elevated plasma TNF, 
Ib6, and -8 is similar to that recorded in humans in response 
to a bolus infusion of endotoxin (17, 19). Furthermore, a 
similar profile of cytokine release has been recorded in vitro 
(22),  reflecting control of cytokine production at the level 
of mRNA concentration within stimulated cells. A reaction 
resembling J-HR has been demonstrated in renal transplant 
patients about 1 h after receiving antithymocyte globulin (23) 
or OKT3 mAb (24) to treat rejection, and transient eleva- 
tion of plasma TNF concentration was associated with fever 
and constitutional symptoms. Treatment of cancer patients 
with high-dose ffNF induces symptomatology very similar 
to that observed during the J-H reaction (25).  In addition, 
experiments extending these studies showed that incubation 
of peripheral blood mononuclear cells in vitro with either 
antithymocyte globulin or OKT 3 mAb induced secretion 
of TNF. 
The stimulus for cytokine generation and release into the 
circulation during the J-HR clearly deserves more detailed 
investigation. The presence of soluble pyrogenic agents has 
been documented in plasma of patients experiencing J-HR 
by bioassay employing intravenous infusion of such plasma 
into rabbits (26). However, the identity of the factor(s) respon- 
sible was not determined. It was suggested that endotoxin 
per se may be the mediator, since the pathophysiological events 
of the J-HR closely resemble those of endotoxin administra- 
tion (27). However although a further study suggested that 
endotoxin might be responsible,  it also demonstrated that 
endotoxin fractions prepared from/g recurrentis and injected 
intravenously into rabbits caused none of the pathophysio- 
logical changes associated with J-HR (38). 
The correlation of disappearance of the spirochetes  from 
the circulation we have demonstrated in the present study, 
with the observed pathophysiological changes and pulsatile 
release of cytokines, suggests that removal of bacteria,  pre- 
sumably by phagocytosis, may represent the stimulus for 
cytokine release. Spirochetes are not removed en masse from 
the circulation until penicillin is administered, and it is likely 
that abnormal forms of the organism, produced in response 
to the antibiotic, are rendered susceptible to phagocytosis by 
macrophages, for example Kupffer cells in the liver. In our 
laboratory,  we have recently shown that phagocytosis of 
pathogens by human macrophage cell lines (THP-1)  or pe- 
ripheral blood monocyte/macrophages  caused a rapid increase 
in mRNA for TNF, IL-6 and -8, and that these cytokines 
are released into the incubating medium (G. E. Griffn, un- 
published observations).  It is therefore possible that phago- 
cytosis of spirochetes made susceptible by the action of peni- 
cillin is an important stimulus for the production and release 
of cytokines. This hypothesis is strengthened by the study 
that a nonendotoxin heat stable particulate pyrogen has been 
isolated from B~ recurrentis, that was proposed as a possible 
stimulus for the J-HR (26). This hypothesis is testable using 
a murine model of Borreliosis (29) in which the administra- 
tion of ampicillin has been shown to produce a J-HR type 
reaction. In addition, a previous study of the interaction of 
Lyme disease spirochetes  with adherent human monocytes 
or murine macrophage cell lines demonstrated the produc- 
tion of Ibl as determined by bioassay (30). This bioassay in 
this study was probably not specific for Ibl and may well 
have detected IIr  Lyme disease spirochetes were phagocy- 
tosed in vitro by macrophages in the absence of opsonins, 
serums, or antibiotics. In addition, experiments were carried 
out that eliminated endotoxin as a stimulus for cytokine re- 
lease in this system. Furthermore, in another series of experi- 
ments, it was shown that Borrelia spirochetes  induced the 
production of leukocyte pyrogen and thromboplastin from 
human blood leukocytes (31). 
Attempts have been made to amdiorate the severity of the 
J-HR using pharmacological agents. The use of intravenous 
hydrocortisone was ineffective (7), and the use of an opiate- 
partial agonist. Meptazinol, was only partially successful (32) 
in relapsing fever. The use of a more potent glucocorticoid, 
prednisone, in the J-HR of syphilis was also unsuccessful in 
reducing symptoms (33). The demonstration in the present 
study that cytokines may have a role to play in the etiology 
of  J-HR may lead to more rational therapy aimed at blocking 
the action ofcytokines using specific mAbs that have already 
been shown to be efficacious in animal models of severe in- 
fection (34,  35). 
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